期刊文献+

早期乳腺癌非前哨淋巴结转移状态预测模型的研究

Study on the Prediction Model of Non-sentinel Lymph Node Metastasis in Early Breast Cancer
下载PDF
导出
摘要 目的:探讨早期乳腺癌非前哨淋巴结(NSLN)转移状态预测模型的预测价值。方法:回顾性分析2015年6月-2021年7月揭阳市人民医院收治的早期乳腺癌患者120例,由纳排标准筛选后最终纳入104例,并依据NSLN是否发生转移将其分为未转移组(67例)和转移组(37例)进行早期乳腺癌NSLN转移状态模型的建立。依据χ^(2)检验、秩和检验比较组间不同病理特征的差异,采用单因素和多因素Logistic回归模型建立早期乳腺癌NSLN转移状态预测模型,并以预测概率做受试者工作特征(ROC)曲线,以曲线下面积(AUC)值评估模型预测能力。结果:两组年龄、月经状态、组织分化级别、是否多灶性、是否伴脉管癌栓、病程、雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)、细胞增殖抗原Ki-67、SLN转移灶大小比较,差异无统计学意义(P>0.05);转移组肿瘤直径>2 cm、SLN阳性数≥3枚、SLN阳性数/活检数>0.5的比例均高于未转移组(P<0.05)。多因素Logistic回归分析结果显示肿瘤直径>2 cm、SLN阳性数≥3枚、SLN阳性数/活检数>0.5为NSLN转移的独立危险因素(P<0.05);ROC曲线结果显示,敏感度为67.60%,特异度为79.10%,AUC值为0.821。结论:以肿瘤直径、SLN阳性数、SLN阳性数/活检数作为自变量构建早期乳腺癌NSLN转移状态预测模型具有较高的预测价值。 Objective:To explore the predictive value of non-sentinel lymph node(NSLN)metastasis prediction model in early breast cancer.Method:A retrospective analysis of 120 patients with early breast cancer admitted to Jieyang People’s Hospital from June 2015 to July 2021.After screening by the admission criteria,104 cases were finally included,they were divided into non-metastatic group(67 cases)and metastatic group(37 cases)according to whether or not NSLN had metastasized,so as to establish the metastatic status model of early breast cancer NSLN.The Chi-square and rank sum test were used to compare the differences of different pathological features between groups,the univariate and multivariate Logistic regression models were used to establish a prediction model for NSLN metastasis in early breast cancer,and the predictive probability was used as the receiver operating characteristic curve(ROC),and use the area under the curve(AUC)value was used to evaluate the predictive ability of the model.Result:There were no significant differences between the two groups in age,menstrual state,grade of tissue differentiation,whether there were multiple lesions,whether there were vascular cancer thrombus,disease course,estrogen receptor(ER),progesterone receptor(PR),human epidermal growth factor receptor 2(HER2),cell proliferation antigen Ki-67 and SLN metastasis size(P>0.05).The ratio of metastatic tumors>2 cm,SLN positive number≥3,and SLN positive number/biopsy number>0.5 in metastatic group were higher than those in non-metastatic group(P<0.05).Multivariate Logistic regression results showed that tumor size>2 cm,number of SLN positives≥3,and number of SLN positives/number of biopsies>0.5 were independent risk factors for NSLN metastasis(P<0.05).ROC curve showed that the sensitivity was 67.60%,the specificity was 79.10%and the AUC value was 0.821.Conclusion:Constructing an early breast cancer NSLN metastasis prediction model with tumor size,number of SLN positives,and number of SLN positives/biopsy as independent variables has high predictive value.
作者 徐国栋 李冰 方泽伟 谢向丽 黄绮国 XU Guodong;LI Bing;FANG Zewei;XIE Xiangli;HUANG Qiguo(不详;Jieyang People’s Hospital,Jieyang 522000,China)
机构地区 揭阳市人民医院
出处 《中外医学研究》 2022年第7期38-41,共4页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 2020年度揭阳市医疗卫生科技创新项目(YLWS082)。
关键词 早期乳腺癌 非前哨淋巴结转移状态 预测模型 LOGISTIC Early breast cancer Non-sentinel lymph node metastasis status Prediction model Logistic
  • 相关文献

参考文献7

二级参考文献101

  • 1王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 2陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:33
  • 3全国肿瘤防治研究办公室 卫生部卫生统计信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997)[M].北京:中国医药科技出版社,2002..
  • 4赵平,陈万青,孔灵芝.中国癌症发病与死亡2003-2007[M].北京:军事医学科学出版社,2012:79-90.
  • 5Krag DN, Anderson SJ,Julian TB, et al. Technical outcomes of sentinel-lymph node resection and conventional axillary-lymph- node dissection in patients with clinically node-negative breast cancer:results from the NSABP ]332 randomized phase UI trial [J]. Lancet Oncol, 2007,8 (10) : 881 888.
  • 6Andersson Y, de Boniface J,Jonsson PE, et al. Axillary recur- rence rate 5 years after negative sentinel node biopsy for breast cancer[J].Br J Surg,2010,99(2) :226-231.
  • 7Kaklamanos IG,Birbas K, Syrigos K, et al. Prospective compari- son of peritumoral and subareolar injection of blue dye alone,for identification of sentinel lymph nodes in patients with early stage breast cancer[J]. J Surg Oncol, 2011,104 (1) : 37-40.
  • 8Shirah GR, Bouton ME, Komenaka IK. Occurrence of prolonged injection site mass with methylene blue but not isosulfan blue af- ter the sentinel node procedure[J]. Arch Surg, 2011,146 (2): 137-141.
  • 9Chintamani, Tandon M, Mishra A, et al. Sentinel lymph node bi- opsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer-a prospective study[J].World J Surg Oncol,2011,9(2) :9-19.
  • 10Ahrendt GM, Laud P, Tjoe J. Does breast tumor location influ- ence success of sentinel lymph node biopsy[J].J Am Coil Surg, 2002,194(3) :278-284.

共引文献889

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部